Case Reports
Journal Article
Add like
Add dislike
Add to saved papers

Bilateral acute myopia and angle closure glaucoma induced by Ma-huang (Ephedra): A case report.

Medicine (Baltimore) 2017 December
RATIONALE: Cases of bilateral acute angle closure have been reported after use of various drugs.

PATIENT CONCERNS: A 52-year-old woman visited the emergency room and complained of acute bilateral ocular pain and decreased vision accompanied by headache, nausea, and vomiting. One day before, she had started a herbal medicine containing Ma-huang for weight loss. On examinations, myopic shift, edematous cornea, increased intraocular pressure, shallow anterior chamber, and thickened choroid on both eyes were observed.

DIAGNOSES: Angle closure glaucoma induced by drug (Ma-huang).

INTERVENTIONS: To promptly quit the offending drug and apply ocular hypotensives and cycloplegics.

OUTCOMES: Her symptoms and signs were relieved after antiglaucoma medications and no significant recurrence has been occurred.

LESSONS: Physicians prescribing weight loss medications containing Ma-huang must be aware of the potentially sight-threatening adverse effect of bilateral acute angle closure.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app